Yet another indication of the importance of emerging markets to the pharma industry—SNY is dropping the “Aventis” from its corporate name: http://en.sanofi-aventis.com/binaries/20110506_PostAG_en_tcm28-32372.pdf (page 2, top) Part of the reason for the name change is that “Sanofi-Aventis” is difficult to pronounce in Chinese!